GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

Rating:
Mkt Outperform
AVII
up 123.64 %

Avi Biopharma, Inc. (AVII) rated Mkt Outperform with price target $2 by Rodman & Renshaw

Posted on: Thursday,  Nov 20, 2008  10:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Sarepta Therapeutics Inc (NASDAQ: SRPT) on 11/20/2008. Previously Rodman & Renshaw rated Buy Sarepta Therapeutics Inc (NASDAQ:
SRPT) on 08/13/2007., when the stock price was $16.20. Since then, Sarepta Therapeutics Inc has gained 123.64% as of 01/19/2016's recent price of $36.23.
If you would have followed the previous Rodman & Renshaw's recommendation on SRPT, you would have gained 123.64% of your investment in 3081 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2008 10:25 AM Buy
None
3.95 12.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/13/2007 9:25 AM Buy
None
16.20 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy